All investors should definitely have quality investment in the Cancer therapy sector either directly or as a proxy.
Very simply. The goal of cancer treatment is to cure or shrink a cancer or stop it from spreading. Hard to make a solid case to not own some.
As one can see the chart above denotes a steady market that says accumulation with slight profit taking is underway.
According to Precedence Research, the global digital therapeutics market size was estimated at USD 7.88 billion in 2024 and is expected to hit around USD 56.76 billion by 2034, poised to grow at a CAGR of 21.83% from 2024 to 2034. North America contributed the largest market share of 44.03% in 2023. (2 days ago.)
Currently at USD3.20, Analysts predict increases in the neighbourhood of;
Key Level #1: $4.34 (+33.54%)
Key Level #2: $4.99 (+53.54%)
Key Level #3: $6.83 (+110.15%)
Key Level #4: $7.74 (+138.15%)
Potential Support: $2.73
52-week hi-lo.
52 Week hi-lo is USD8.50 to USD3.50. Even the frequent price pops should intrigue traders. This story and Company are the very embodiment of a dollar cost average. Besides maintaining exposure, investor with be there for natural growth, the M&A sector, and simply a way to keep apprised amend new cutting-edge therapies.
The life you save through your investment could be you own.
Or Mine.
